Corticosteroids may leads to higher clinical improvement (dichotomous) compared with placebo (low certainty).
Biologics showed no clear difference in clinical improvement (dichotomous) compared with placebo (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether corticosteroids changes clinical improvement (dichotomous) compared with placebo (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether leukotriene receptor antagonist changes clinical improvement at 26 weeks (dichotomous) compared with placebo (very low certainty).